BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31390573)

  • 21. Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia.
    Delitto D; Judge SM; Delitto AE; Nosacka RL; Rocha FG; DiVita BB; Gerber MH; George TJ; Behrns KE; Hughes SJ; Wallet SM; Judge AR; Trevino JG
    Oncotarget; 2017 Jan; 8(1):1177-1189. PubMed ID: 27901481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle.
    Wei L; Wang R; Wazir J; Lin K; Song S; Li L; Pu W; Zhao C; Wang Y; Su Z; Wang H
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
    Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
    Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
    Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
    Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.
    Bonetto A; Aydogdu T; Kunzevitzky N; Guttridge DC; Khuri S; Koniaris LG; Zimmers TA
    PLoS One; 2011; 6(7):e22538. PubMed ID: 21799891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer.
    Babic A; Rosenthal MH; Sundaresan TK; Khalaf N; Lee V; Brais LK; Loftus M; Caplan L; Denning S; Gurung A; Harrod J; Schawkat K; Yuan C; Wang QL; Lee AA; Biller LH; Yurgelun MB; Ng K; Nowak JA; Aguirre AJ; Bhatia SN; Vander Heiden MG; Van Den Eeden SK; Caan BJ; Wolpin BM
    Nat Commun; 2023 Jul; 14(1):4317. PubMed ID: 37463915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
    White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic cancer cachexia: three dimensions of a complex syndrome.
    Kordes M; Larsson L; Engstrand L; Löhr JM
    Br J Cancer; 2021 May; 124(10):1623-1636. PubMed ID: 33742145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor protein function in skeletal abdominal muscle of cachectic cancer patients.
    Taskin S; Stumpf VI; Bachmann J; Weber C; Martignoni ME; Friedrich O
    J Cell Mol Med; 2014 Jan; 18(1):69-79. PubMed ID: 24251822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.
    Hetzler KL; Hardee JP; Puppa MJ; Narsale AA; Sato S; Davis JM; Carson JA
    Biochim Biophys Acta; 2015 May; 1852(5):816-25. PubMed ID: 25555992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
    Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
    Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
    Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk.
    Wu J; Dong J; Verzola D; Hruska K; Garibotto G; Hu Z; Mitch WE; Thomas SS
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1210-1227. PubMed ID: 31507080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A TGF-β/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer.
    Dasgupta A; Gibbard DF; Schmitt RE; Arneson-Wissink PC; Ducharme AM; Bruinsma ES; Hawse JR; Jatoi A; Doles JD
    Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2215095120. PubMed ID: 37585460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.
    Judge SM; Wu CL; Beharry AW; Roberts BM; Ferreira LF; Kandarian SC; Judge AR
    BMC Cancer; 2014 Dec; 14():997. PubMed ID: 25539728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D repletion ameliorates adipose tissue browning and muscle wasting in infantile nephropathic cystinosis-associated cachexia.
    Cheung WW; Hao S; Wang Z; Ding W; Zheng R; Gonzalez A; Zhan JY; Zhou P; Li S; Esparza MC; Hoffman HM; Lieber RL; Mak RH
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):120-134. PubMed ID: 31721480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C26 cancer-induced muscle wasting is IKKβ-dependent and NF-kappaB-independent.
    Cornwell EW; Mirbod A; Wu CL; Kandarian SC; Jackman RW
    PLoS One; 2014; 9(1):e87776. PubMed ID: 24489962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.
    Fukawa T; Yan-Jiang BC; Min-Wen JC; Jun-Hao ET; Huang D; Qian CN; Ong P; Li Z; Chen S; Mak SY; Lim WJ; Kanayama HO; Mohan RE; Wang RR; Lai JH; Chua C; Ong HS; Tan KK; Ho YS; Tan IB; Teh BT; Shyh-Chang N
    Nat Med; 2016 Jun; 22(6):666-71. PubMed ID: 27135739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
    Greco SH; Tomkötter L; Vahle AK; Rokosh R; Avanzi A; Mahmood SK; Deutsch M; Alothman S; Alqunaibit D; Ochi A; Zambirinis C; Mohaimin T; Rendon M; Levie E; Pansari M; Torres-Hernandez A; Daley D; Barilla R; Pachter HL; Tippens D; Malik H; Boutajangout A; Wisniewski T; Miller G
    PLoS One; 2015; 10(7):e0132786. PubMed ID: 26172047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
    Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.